viewpoint: china has the upper hand in cancer cell therapy
.
.-related side effects. its manufacturer, eli lilly, plans to submit a new drug application to the fda in the second half of 2018.
.
yesterday they welcomed the findings of coroner patrick mcgurgan, who criticised the staff caring for mrs cavanagh over a series of missed opportunities.
.